These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
345 related items for PubMed ID: 11376302
1. Comparative effects of carvedilol and metoprolol on left ventricular ejection fraction in heart failure: results of a meta-analysis. Packer M, Antonopoulos GV, Berlin JA, Chittams J, Konstam MA, Udelson JE. Am Heart J; 2001 Jun; 141(6):899-907. PubMed ID: 11376302 [Abstract] [Full Text] [Related]
2. Carvedilol: use in chronic heart failure. Doughty RN, White HD. Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):21-31. PubMed ID: 17187454 [Abstract] [Full Text] [Related]
3. Beta-blockade in heart failure: a comparison of carvedilol with metoprolol. Sanderson JE, Chan SK, Yip G, Yeung LY, Chan KW, Raymond K, Woo KS. J Am Coll Cardiol; 1999 Nov 01; 34(5):1522-8. PubMed ID: 10551702 [Abstract] [Full Text] [Related]
4. Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart. Gilbert EM, Abraham WT, Olsen S, Hattler B, White M, Mealy P, Larrabee P, Bristow MR. Circulation; 1996 Dec 01; 94(11):2817-25. PubMed ID: 8941107 [Abstract] [Full Text] [Related]
5. Comparative effects of carvedilol and metoprolol on regional vascular responses to adrenergic stimuli in normal subjects and patients with chronic heart failure. Hryniewicz K, Androne AS, Hudaihed A, Katz SD. Circulation; 2003 Aug 26; 108(8):971-6. PubMed ID: 12912816 [Abstract] [Full Text] [Related]
6. Differential effects of beta-blockers in patients with heart failure: A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol. Metra M, Giubbini R, Nodari S, Boldi E, Modena MG, Dei Cas L. Circulation; 2000 Aug 01; 102(5):546-51. PubMed ID: 10920067 [Abstract] [Full Text] [Related]
7. Carvedilol versus metoprolol in the acute phase of myocardial infarction: Bonnemeier H, Ortak J, Tölg R, Witt M, Schmidt J, Wiegand UK, Bode F, Schunkert H, Richardt G. Pacing Clin Electrophysiol; 2005 Jan 01; 28 Suppl 1():S222-6. PubMed ID: 15683501 [Abstract] [Full Text] [Related]
8. Do metoprolol and carvedilol have equivalent effects on diurnal heart rate in patients with chronic heart failure? Sanderson JE, Leung LY, Chan SK, Yip GW, Fung JW, Yu CM. Eur J Heart Fail; 2005 Aug 01; 7(5):874-7. PubMed ID: 16043407 [Abstract] [Full Text] [Related]
9. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial. Jabbour A, Macdonald PS, Keogh AM, Kotlyar E, Mellemkjaer S, Coleman CF, Elsik M, Krum H, Hayward CS. J Am Coll Cardiol; 2010 Apr 27; 55(17):1780-7. PubMed ID: 20413026 [Abstract] [Full Text] [Related]
10. Carvedilol in the treatment of chronic heart failure: lessons from the Carvedilol Or Metoprolol European Trial. Kveiborg B, Major-Petersen A, Christiansen B, Torp-Pedersen C. Vasc Health Risk Manag; 2007 Apr 27; 3(1):31-7. PubMed ID: 17583173 [Abstract] [Full Text] [Related]
11. Exchange of beta-blockers in heart failure patients. Experiences from the poststudy phase of COMET (the Carvedilol or Metoprolol European Trial). Di Lenarda A, Remme WJ, Charlesworth A, Cleland JG, Lutiger B, Metra M, Komajda M, Torp-Pedersen C, Scherhag A, Swedberg K, Poole-Wilson PA, COMET investors. Eur J Heart Fail; 2005 Jun 27; 7(4):640-9. PubMed ID: 15921806 [Abstract] [Full Text] [Related]
12. Prospective crossover comparison of carvedilol and metoprolol in patients with chronic heart failure. Maack C, Elter T, Nickenig G, LaRosee K, Crivaro M, Stäblein A, Wuttke H, Böhm M. J Am Coll Cardiol; 2001 Oct 27; 38(4):939-46. PubMed ID: 11583862 [Abstract] [Full Text] [Related]
13. Effect of beta-blocker therapy on left atrial function in patients with heart failure: comparison of metoprolol succinate with carvedilol. Arslan S, Erol MK, Bozkurt E, Acikel M, Gundogdu F, Atesal S, Senocak H. Int J Cardiovasc Imaging; 2007 Oct 27; 23(5):549-55. PubMed ID: 17171429 [Abstract] [Full Text] [Related]
14. Carvedilol exerts more potent antiadrenergic effect than metoprolol in heart failure. Kohno T, Yoshikawa T, Yoshizawa A, Nakamura I, Anzai T, Satoh T, Ogawa S. Cardiovasc Drugs Ther; 2005 Oct 27; 19(5):347-55. PubMed ID: 16382297 [Abstract] [Full Text] [Related]
15. Beta-receptor selectivity of carvedilol and metoprolol succinate in patients with heart failure (SELECT trial): a randomized dose-ranging trial. Zebrack JS, Munger M, Macgregor J, Lombardi WL, Stoddard GP, Gilbert EM. Pharmacotherapy; 2009 Aug 27; 29(8):883-90. PubMed ID: 19637941 [Abstract] [Full Text] [Related]
16. Comparison of pharmacodynamics between carvedilol and metoprolol in rats with isoproterenol-induced cardiac hypertrophy: effects of carvedilol enantiomers. Hanada K, Asari K, Saito M, Kawana J, Mita M, Ogata H. Eur J Pharmacol; 2008 Jul 28; 589(1-3):194-200. PubMed ID: 18534575 [Abstract] [Full Text] [Related]
17. Regression of left ventricular remodeling in chronic heart failure: Comparative and combined effects of captopril and carvedilol. Khattar RS, Senior R, Soman P, van der Does R, Lahiri A. Am Heart J; 2001 Oct 28; 142(4):704-13. PubMed ID: 11579363 [Abstract] [Full Text] [Related]
18. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study. Olsen SL, Gilbert EM, Renlund DG, Taylor DO, Yanowitz FD, Bristow MR. J Am Coll Cardiol; 1995 May 28; 25(6):1225-31. PubMed ID: 7722114 [Abstract] [Full Text] [Related]
19. The effects of combined versus selective adrenergic blockade on left ventricular and systemic hemodynamics, myocardial substrate preference, and regional perfusion in conscious dogs with dilated cardiomyopathy. Nikolaidis LA, Poornima I, Parikh P, Magovern M, Shen YT, Shannon RP. J Am Coll Cardiol; 2006 May 02; 47(9):1871-81. PubMed ID: 16682315 [Abstract] [Full Text] [Related]
20. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial. Hori M, Sasayama S, Kitabatake A, Toyo-oka T, Handa S, Yokoyama M, Matsuzaki M, Takeshita A, Origasa H, Matsui K, Hosoda S, MUCHA Investigators. Am Heart J; 2004 Feb 02; 147(2):324-30. PubMed ID: 14760332 [Abstract] [Full Text] [Related] Page: [Next] [New Search]